ES226833A1 - UN MÉTODO PARA LA PRODUCCIoN DE UN AGENTE ANTIBIoTICO - Google Patents

UN MÉTODO PARA LA PRODUCCIoN DE UN AGENTE ANTIBIoTICO

Info

Publication number
ES226833A1
ES226833A1 ES0226833A ES226833A ES226833A1 ES 226833 A1 ES226833 A1 ES 226833A1 ES 0226833 A ES0226833 A ES 0226833A ES 226833 A ES226833 A ES 226833A ES 226833 A1 ES226833 A1 ES 226833A1
Authority
ES
Spain
Prior art keywords
vancomycin
culture medium
antibiotic
preparation
aerobros
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0226833A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES226833A1 publication Critical patent/ES226833A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces

Abstract

Un método de producción de un agente antibiótico que se caracteriza por el cultivo en condiciones aerobrás de una cepa de Streptomyces orientalis productora de vancomicina en un medio de cultivo que contenga fuentes asimilables de hidratos de carbono, nitrógeno y sales inorgánicas, hasta que se produzca actividad antibiótica considerable por el citado microorganismo en el medio de cultivo mencionado.
ES0226833A 1955-09-16 1956-02-20 UN MÉTODO PARA LA PRODUCCIoN DE UN AGENTE ANTIBIoTICO Expired ES226833A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US534666A US3067099A (en) 1955-09-16 1955-09-16 Vancomycin and method for its preparation

Publications (1)

Publication Number Publication Date
ES226833A1 true ES226833A1 (es) 1956-04-16

Family

ID=24131018

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0226833A Expired ES226833A1 (es) 1955-09-16 1956-02-20 UN MÉTODO PARA LA PRODUCCIoN DE UN AGENTE ANTIBIoTICO

Country Status (2)

Country Link
US (1) US3067099A (es)
ES (1) ES226833A1 (es)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3332847A (en) * 1964-12-08 1967-07-25 Marilyn J Bachler Almarcetin and its production by streptomyces albus
US3342681A (en) * 1965-04-16 1967-09-19 Upjohn Co Antibiotic armentomycin and a process for producing the same
US4440753A (en) * 1982-03-15 1984-04-03 Eli Lilly And Company Purification of glycopeptide antibiotics using non-functional resins
US4604239A (en) * 1982-03-24 1986-08-05 Eli Lilly And Company Antibiotics
US4713331A (en) * 1982-03-24 1987-12-15 Eli Lilly And Company Microbial production of A41030 antibiotics
US4537770A (en) * 1982-03-24 1985-08-27 Eli Lilly And Company A41030 antibiotics
US4695545A (en) * 1982-03-24 1987-09-22 Eli Lilly And Company Culture and process for producing A41030 antibiotics
US4559323A (en) * 1982-03-24 1985-12-17 Eli Lilly And Company A41030 Antibiotics
US4462942A (en) * 1982-07-30 1984-07-31 Eli Lilly And Company A47934 Antibiotic and process for production thereof
US4495179A (en) * 1982-12-20 1985-01-22 Eli Lilly And Company A51568 Antibiotic and process for producing thereof
US4558009A (en) * 1982-12-20 1985-12-10 Eli Lilly And Company Process for producing antibiotic A-51568 by fermentation and microorganism
US4791064A (en) * 1983-07-07 1988-12-13 Smithkline Beckman Corporation Plasmids from nocardia
GR81191B (en) * 1983-12-12 1985-04-08 Lilly Co Eli Vancomycin purification improvement and product
US4558008A (en) * 1983-12-13 1985-12-10 Eli Lilly And Company Process for production of A-51568B antibiotic
US4670258A (en) * 1984-02-10 1987-06-02 Vanderbilt University Storable prepackaged aqueous solutions of vancomycin
US4548925A (en) * 1984-04-16 1985-10-22 Eli Lilly And Company Antibiotic M43A, pharmaceutical composition and method of use
US4552701A (en) * 1984-04-16 1985-11-12 Eli Lilly And Company Glycopeptide antibiotics and process of preparation
US4548924A (en) * 1984-04-16 1985-10-22 Eli Lilly And Company Antibiotics M43B and M43C, pharmaceutical composition and method of use
US4547488A (en) * 1984-04-16 1985-10-15 Eli Lilly And Company Antibiotic M43D, pharmaceutical compositions and method of use
EP0159180B1 (en) * 1984-04-16 1989-08-09 Eli Lilly And Company Improvements in and relating to antibiotics m43a, m43b, m43c and m43d
US4698327A (en) * 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
US4643987A (en) * 1985-08-14 1987-02-17 Eli Lilly And Company Modified glycopeptides
US4639433A (en) * 1985-08-14 1987-01-27 Eli Lilly And Company Glycopeptide derivatives
GB8600952D0 (en) * 1986-01-16 1986-02-19 Glaxo Group Ltd Antibiotic production
GB8618445D0 (en) * 1986-07-29 1986-09-03 Lepetit Spa Antibiotic a 42867
EG18377A (en) * 1986-09-19 1993-04-30 Lilly Co Eli Process for preparing glycopeptide antibiotics
GB8700513D0 (en) * 1987-01-09 1987-02-11 Pfizer Ltd Antibiotics produced by fermentation
US4845194A (en) * 1987-02-27 1989-07-04 Eli Lilly And Company Glycopeptide recovery process
US4996148A (en) * 1987-07-13 1991-02-26 Eli Lilly And Company A80407 antibiotics
US5213797A (en) * 1987-07-13 1993-05-25 Eli Lilly And Company A80407 antibiotics
US4885275A (en) * 1987-10-15 1989-12-05 Eli Lilly And Company Vancomycin-HCL solutions and the lyophilization thereof
US5037652A (en) * 1987-12-28 1991-08-06 Eli Lilly And Company Vancomycin precipitation process
CA1320312C (en) * 1987-12-28 1993-07-13 Harold Raymond Catt Improved vancomycin precipitation process
GB8801899D0 (en) * 1988-01-28 1988-02-24 Lepetit Spa Antibiotic a42867 derivative
US5534420A (en) * 1988-07-28 1996-07-09 Eli Lilly And Company Biotransformation of glycopeptide antibiotics
DE69031721T2 (de) * 1989-07-18 1998-03-19 Biosearch Italia Spa Aus Dalbaheptide hergestellte Pentapeptid-Antibiotika
JP2577133B2 (ja) * 1989-11-27 1997-01-29 スティフティング フォール ド テフニスヘ ウェッテンスハッペン 船舶のプロペラ
US5149784A (en) * 1990-07-10 1992-09-22 Abbott Laboratories Process for making vancomycin
US5258495A (en) * 1990-07-10 1993-11-02 Abbott Laboratories Process for making vancomycin HC1
US5574135A (en) * 1990-07-10 1996-11-12 Abbott Laboratories Process for making vancomycin
US5451570A (en) * 1990-07-27 1995-09-19 Hoechst Aktiengesellschaft Antibiotic, balhimycin, a process for its production and its use as pharmaceutical
IN171883B (es) * 1990-07-27 1993-01-30 Hoechst India
WO1993021207A1 (en) * 1992-04-20 1993-10-28 Abbott Laboratories Process for making vancomycin
PE40996A1 (es) * 1994-01-28 1996-10-14 Lilly Co Eli Derivado de antibiotico de glucopeptido
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
US6416546B1 (en) * 1997-06-04 2002-07-09 Unitika Ltd. Medical device and production method thereof
US6028051A (en) * 1997-07-23 2000-02-22 Ambi Inc. Method for the treatment of staphylococcal disease
US6274157B1 (en) * 2000-05-15 2001-08-14 Development Center For Biotechnology Strains of Streptomyces and relevant uses thereof
US6475522B1 (en) 2000-08-30 2002-11-05 Hammond Group, Inc. Synthetic polymer compositions containing antibiotics as antidegradants
GB0026924D0 (en) * 2000-11-03 2000-12-20 Univ Cambridge Tech Antibacterial agents
US6734165B2 (en) * 2001-08-23 2004-05-11 The Trustees Of Columbia University In The City Of New York Method for re-sensitizing vancomycin resistant bacteria which selectively cleave a cell wall depsipeptide
US20030180766A1 (en) * 2002-01-24 2003-09-25 Ecopia Biosciences, Inc. Method, system and knowledge repository for identifying a secondary metabolite from a microorganism
TWI342312B (en) * 2003-10-22 2011-05-21 Theravance Inc Hydrochloride salts of a glycopeptide phosphonate derivative
US20080161536A1 (en) * 2006-12-29 2008-07-03 Abbott Laboratories Vancomycin b hydrochloride crystalline form 1
KR20080075979A (ko) * 2007-02-14 2008-08-20 주식회사 바이오앤진 아미코라톱시스 오리엔탈리스 변이주 및 이를 이용한반코마이신 염산염의 제조방법
BRPI0910848A2 (pt) * 2008-04-28 2015-08-18 Univ Michigan Tech Elementos de promotores específicos da fibra
KR101101663B1 (ko) 2009-01-13 2011-12-30 (주) 제노텍 반코마이신 습체의 정제방법
US9572774B2 (en) * 2011-05-19 2017-02-21 Savara Inc. Dry powder vancomycin compositions and associated methods
CN104043104B (zh) 2013-03-15 2018-07-10 浙江创新生物有限公司 含盐酸万古霉素的喷雾干粉及其工业化制备方法
JP6713003B2 (ja) 2015-01-26 2020-06-24 インスティテュート フォー クリニカル ファーマコダイナミクス, インコーポレイテッド 感染症を患う被験体における抗感染症療法の期間を短縮する方法

Also Published As

Publication number Publication date
US3067099A (en) 1962-12-04

Similar Documents

Publication Publication Date Title
ES226833A1 (es) UN MÉTODO PARA LA PRODUCCIoN DE UN AGENTE ANTIBIoTICO
ES203451A1 (es) MEJORAS INTRODUCIDAS EN LA PREPARACIoN DE UN MEDIO DE FERMENTACIoN ADECUADO PARA EL CULTIVO DE BACTERIAS PRODUCTORAS DE ESTRETOKINASA Y ESTREPTODORNASA
ES394210A1 (es) Un procedimiento para la preparacion de una nueva sustanciaantibiotica de amplio espectro antimicrobiano.
ES210504A1 (es) Procedimiento para la preparacion de un nuevo agente antibiotico y de sus sales
ES228443A1 (es) PROCEDIMIENTO DE FABRICACIoN DE UN ANTIBIoTICO áCIDO
ES247066A1 (es) Procedimiento para la obtencion de amino-9-d-psicofuranosilpurina
ES231758A1 (es) PROCEDIMIENTO PARA LA PRODUCCIoN DE UN ANTIBIoTICO NUEVO
ES226255A3 (es) UN PROCEDIMIENTO PARA PRODUCIR UN NUEVO ANTIBIoTICO
ES226626A1 (es) Un método para producir un preparado antibiótico, conteniendo tiostrepton
ES220052A1 (es) Un procedimiento para producir el antibiótico jn-21
ES228089A1 (es) UN MÉTODO DE PRODUCCIoN DE UN ANTIBIoTICO
ES217171A1 (es) Un metodo para la obtencion de sustancias antibioticas
ES221830A1 (es) Un procedimiento para la producción de estreptogramina
ES227982A1 (es) UN PROCEDIMIENTO PARA LA OBTENCIoN DE COMPUESTOS ESTEROIDES POR FERMENTACIoN.
ES214921A1 (es) Un procedimeinto para la preparacion de antibioticos
ES228188A1 (es) UN PROCEDIMIENTO PARA LA PRODUCCIoN DE COBALáMINAS.
ES203537A1 (es) UN PROCEDIMIENTO PARA LA PRODUCCIoN DE MEZCLAS DE ESTREPTOKINASA Y ESTREPTODORNASA
ES220681A1 (es) UN PROCEDIMIENTO DE OBTENCIoN DE ANTIBIoTICOS
ES229318A1 (es) UN PROCEDIMIENTO PARA LA PRODUCCIoN DE UNOS ANTIBIOTICOS
ES237387A1 (es) UN PROCESO PARA LA PRODUCCIoN DE UN NUEVO ANTIBIoTICO, LA CANAMICINA
ES440543A1 (es) Un procedimiento para la produccion de un antibiotico perte-neciente al complejo gentamicina c.
ES236312A1 (es) Procedimiento para la produccion de pimaricina
ES211797A1 (es) Procedimiento para la preparacion de un antibiotico
ES262202A1 (es) Un procedimiento para producir un complejo antibiótico
ES299268A1 (es) Procedimiento para la obtención de un nuevo antibiótico